NSD1 mediates antagonism between SWI/SNF and polycomb complexes and is required for transcriptional activation upon EZH2 inhibition.

[1]  Yin Tang,et al.  The H3K36me2 methyltransferase NSD1 modulates H3K27ac at active enhancers to safeguard gene expression , 2021, Nucleic acids research.

[2]  N. Jabado,et al.  Polycomb repressive complex 2 in the driver's seat of childhood and young adult brain tumours. , 2021, Trends in cell biology.

[3]  B. Garcia,et al.  Chromatin dysregulation associated with NSD1 mutation in head and neck squamous cell carcinoma , 2021, Cell reports.

[4]  C. Allis,et al.  Depletion of H3K36me2 recapitulates epigenomic and phenotypic changes induced by the H3.3K36M oncohistone mutation , 2021, Proceedings of the National Academy of Sciences.

[5]  B. Garcia,et al.  A Workflow for Ultra-rapid Analysis of Histone Post-translational Modifications with Direct-injection Mass Spectrometry. , 2020, Bio-protocol.

[6]  Antoine H. F. M. Peters,et al.  Nuclear interacting SET domain protein 1 inactivation impairs GATA1-regulated erythroid differentiation and causes erythroleukemia , 2020, Nature Communications.

[7]  D. Ellison,et al.  Phase II study of alisertib as a single agent in recurrent or progressive atypical teratoid rhabdoid tumors. , 2020 .

[8]  C. Roberts,et al.  The SWI/SNF complex in cancer — biology, biomarkers and therapy , 2020, Nature Reviews Clinical Oncology.

[9]  S. Baylin,et al.  Epigenetic Therapy for Epithelioid Sarcoma , 2020, Cell.

[10]  Takeshi Noda,et al.  Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping , 2020, Nature Communications.

[11]  R. Margueron,et al.  Drugging histone methyltransferases in cancer. , 2020, Current opinion in chemical biology.

[12]  Jinghui Zhang,et al.  ChIPseqSpikeInFree: a ChIP-seq normalization approach to reveal global changes in histone modifications without spike-in , 2019, Bioinform..

[13]  D. Reinberg,et al.  LEDGF and HDGF2 relieve the nucleosome-induced barrier to transcription in differentiated cells , 2019, Science Advances.

[14]  A. Bracken,et al.  PRC2 functions in development and congenital disorders , 2019, Development.

[15]  Matthew J. Meiners,et al.  H3K36me2 recruits DNMT3A and shapes the intergenic DNA methylation landscape , 2019, Nature.

[16]  D. Reinberg,et al.  PRC2 is high maintenance , 2019, Genes & development.

[17]  C. Verrijzer,et al.  Dangerous liaisons: interplay between SWI/SNF, NuRD, and Polycomb in chromatin regulation and cancer , 2019, Genes & development.

[18]  Qi Liu,et al.  Inhibition of MYC by the SMARCB1 tumor suppressor , 2019, Nature Communications.

[19]  V. Reuter,et al.  Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases , 2019, Modern Pathology.

[20]  Jon P. Connelly,et al.  CRIS.py: A Versatile and High-throughput Analysis Program for CRISPR-based Genome Editing , 2019, Scientific Reports.

[21]  Beisi Xu,et al.  Differentiation of human pluripotent stem cells into neurons or cortical organoids requires transcriptional co-regulation by UTX and 53BP1 , 2019, Nature Neuroscience.

[22]  David T. W. Jones,et al.  Comprehensive Analysis of Chromatin States in Atypical Teratoid/Rhabdoid Tumor Identifies Diverging Roles for SWI/SNF and Polycomb in Gene Regulation. , 2019, Cancer cell.

[23]  Aman N. Patel,et al.  Pediatric Cancer Variant Pathogenicity Information Exchange (PeCanPIE): a cloud-based platform for curating and classifying germline variants , 2018, bioRxiv.

[24]  Darren J. Fitzpatrick,et al.  The H3K36me2 Methyltransferase Nsd1 Demarcates PRC2-Mediated H3K27me2 and H3K27me3 Domains in Embryonic Stem Cells. , 2018, Molecular cell.

[25]  Wai Lim Ku,et al.  SMARCB1 is required for widespread BAF complex-mediated activation of enhancers and bivalent promoters , 2017, Nature Genetics.

[26]  J. Licht,et al.  The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer. , 2017, Cold Spring Harbor perspectives in medicine.

[27]  Donavan T. Cheng,et al.  Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients , 2017, Nature Medicine.

[28]  P. Varlet,et al.  Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancers , 2017, Oncotarget.

[29]  P. Park,et al.  The SWI/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers , 2017, Nature Communications.

[30]  Wai Lim Ku,et al.  Smarca4 ATPase mutations disrupt direct eviction of PRC1 from chromatin , 2016, Nature Genetics.

[31]  Shawn M. Gillespie,et al.  SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation , 2016, Nature Genetics.

[32]  P. Park,et al.  ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice , 2016, Nature Genetics.

[33]  Emma J. Chory,et al.  Dynamics of BAF- Polycomb Complex Opposition on Heterochromatin in Normal and Oncogenic States , 2016, Nature Genetics.

[34]  G. Cagney,et al.  Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells* , 2016, Molecular & Cellular Proteomics.

[35]  C. Allis,et al.  The molecular hallmarks of epigenetic control , 2016, Nature Reviews Genetics.

[36]  Luciano Di Croce,et al.  The dynamic interactome and genomic targets of Polycomb complexes during stem cell differentiation , 2016, Nature Structural &Molecular Biology.

[37]  Fidel Ramírez,et al.  deepTools2: a next generation web server for deep-sequencing data analysis , 2016, Nucleic Acids Res..

[38]  Steven J. M. Jones,et al.  Genome-Wide Profiles of Extra-cranial Malignant Rhabdoid Tumors Reveal Heterogeneity and Dysregulated Developmental Pathways. , 2016, Cancer cell.

[39]  Roland Eils,et al.  Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes. , 2016, Cancer cell.

[40]  C. Roberts,et al.  Targeting EZH2 in cancer , 2016, Nature Medicine.

[41]  Thomas P. Howard,et al.  SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2 , 2015, Nature Medicine.

[42]  Tim J. Wigle,et al.  Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma , 2014, Molecular Cancer Therapeutics.

[43]  Miguel Beato,et al.  bwtool: a tool for bigWig files , 2014, Bioinform..

[44]  Charity W. Law,et al.  voom: precision weights unlock linear model analysis tools for RNA-seq read counts , 2014, Genome Biology.

[45]  German Tischler,et al.  biobambam: tools for read pair collation based algorithms on BAM files , 2013, Source Code for Biology and Medicine.

[46]  Tim J. Wigle,et al.  Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2 , 2013, Proceedings of the National Academy of Sciences.

[47]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[48]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[49]  Tim J. Wigle,et al.  A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells. , 2012, Nature chemical biology.

[50]  Yan Liu,et al.  EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations , 2012, Nature.

[51]  Lei Jin,et al.  A687V EZH2 is a gain‐of‐function mutation found in lymphoma patients , 2012, FEBS letters.

[52]  Marc D. Perry,et al.  ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia , 2012, Genome research.

[53]  Bronwen L. Aken,et al.  GENCODE: The reference human genome annotation for The ENCODE Project , 2012, Genome research.

[54]  Kristian Cibulskis,et al.  A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers. , 2012, The Journal of clinical investigation.

[55]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[56]  Yong Jiang,et al.  Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27) , 2012, Proceedings of the National Academy of Sciences.

[57]  Katrina Tatton-Brown,et al.  Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height , 2011, Oncotarget.

[58]  C. Roberts,et al.  SWI/SNF nucleosome remodellers and cancer , 2011, Nature Reviews Cancer.

[59]  D. Reinberg,et al.  The Polycomb complex PRC2 and its mark in life , 2011, Nature.

[60]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[61]  R. Copeland,et al.  Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas , 2010, Proceedings of the National Academy of Sciences.

[62]  Scott L Pomeroy,et al.  Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation. , 2010, Cancer cell.

[63]  Richard A. Moore,et al.  ARID1A mutations in endometriosis-associated ovarian carcinomas. , 2010, The New England journal of medicine.

[64]  J. Rice,et al.  Role for the nuclear receptor-binding SET domain protein 1 (NSD1) methyltransferase in coordinating lysine 36 methylation at histone 3 with RNA polymerase II function , 2010, Proceedings of the National Academy of Sciences.

[65]  P. Park,et al.  CpG Islands Recruit a Histone H3 Lysine 36 Demethylase , 2010, Molecular cell.

[66]  Aaron R. Quinlan,et al.  Bioinformatics Applications Note Genome Analysis Bedtools: a Flexible Suite of Utilities for Comparing Genomic Features , 2022 .

[67]  M. Robinson,et al.  A scaling normalization method for differential expression analysis of RNA-seq data , 2010, Genome Biology.

[68]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[69]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[70]  P. Park,et al.  Design and analysis of ChIP-seq experiments for DNA-binding proteins , 2008, Nature Biotechnology.

[71]  Y. Tsukada,et al.  The H3K36 demethylase Jhdm1b/Kdm2b regulates cell proliferation and senescence through p15Ink4b , 2008, Nature Structural &Molecular Biology.

[72]  C. Verrijzer,et al.  SWI/SNF Mediates Polycomb Eviction and Epigenetic Reprogramming of the INK4b-ARF-INK4a Locus , 2008, Molecular and Cellular Biology.

[73]  Olivier Delattre,et al.  Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer , 1998, Nature.